Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.

[1]  F. Giuliante,et al.  Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[2]  A. Mantovani,et al.  NAFLD, MAFLD and DAFLD. , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[3]  F. Giuliante,et al.  The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry. , 2020, Annals of surgery.

[4]  F. Giuliante,et al.  Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience , 2020, Updates in Surgery.

[5]  A. Sanyal,et al.  MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. , 2020, Gastroenterology.

[6]  M. Ronot,et al.  Metabolic syndrome and hepatic surgery. , 2019, Journal of visceral surgery.

[7]  N. Syn,et al.  Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma. , 2019, Journal of the American College of Surgeons.

[8]  J. Saunders,et al.  Alcohol Use Disorders in ICD-11: past, present and future. , 2019, Alcoholism, clinical and experimental research.

[9]  T. Pawlik,et al.  Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC , 2019, Journal of Gastrointestinal Surgery.

[10]  H. El‐Serag,et al.  Epidemiology and Management of Hepatocellular Carcinoma. , 2019, Gastroenterology.

[11]  G. Goh,et al.  Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades , 2018, Digestive Diseases and Sciences.

[12]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[13]  N. Giama,et al.  More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[14]  Jun Li,et al.  Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC , 2018, Journal of Gastrointestinal Surgery.

[15]  H. El‐Serag,et al.  Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma , 2017, Cancer control : journal of the Moffitt Cancer Center.

[16]  D. Wendum,et al.  Temporal trends, clinical patterns and outcomes of NAFLD‐related HCC in patients undergoing liver resection over a 20‐year period , 2017, Alimentary pharmacology & therapeutics.

[17]  Rongqian Wu,et al.  Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis , 2017, PloS one.

[18]  Body Mass Index and Waistline are Predictors of Survival for Hepatocellular Carcinoma After Hepatectomy , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[19]  F. Giuliante,et al.  Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC. , 2015, Journal of hepatology.

[20]  H. El‐Serag,et al.  Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  V. Paradis,et al.  Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome , 2013, The British journal of surgery.

[22]  H. El‐Serag,et al.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  M. Choti,et al.  Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. , 2012, Surgery.

[24]  A. Tsung,et al.  Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease , 2012, Hepatology.

[25]  J. Ertle,et al.  Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis , 2011, International journal of cancer.

[26]  K. Hatakeyama,et al.  Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease , 2011, Journal of Gastrointestinal Surgery.

[27]  J. Ijzermans,et al.  Systematic review and meta‐analysis of steatosis as a risk factor in major hepatic resection , 2010, The British journal of surgery.

[28]  O. Farges,et al.  Safety of Liver Resections in Obese and Overweight Patients , 2010, World Journal of Surgery.

[29]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[30]  A. Zhu,et al.  Metabolic syndrome and hepatocellular carcinoma , 2009, Cancer.

[31]  V. Paradis,et al.  Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.

[32]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  S. Fan,et al.  Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? , 2002, American Journal of Gastroenterology.